GLAUKOS CORP (GKOS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for GKOS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GKOS | Lead Independent Director | 60 | ["Former Chief Executive Officer, Revance Therapeutics, Inc.","Chief Executive Officer, Revance Therapeutics, Inc.","Chairman, President and Chief Executive Officer, ZELTIQ Aesthetics, Inc.","Managing Director, RWI Ventures, Inc.","Various Executive Positions for United States Surgical Corporation, Guidant Corporation, Devices for Vascular Intervention Inc., Perclose, Inc., and Ventrica, Inc."] | ["Audit","Compensation","Nominating and Governance"] | 2026 |
Biography sourced from the proxy statement filing.
Age 60, Independent Director Since 2014, Lead Independent Director Since 2021 BOARD COMMITTEES Compensation, Nominating and Governance (Chair) TERM EXPIRES: 2028 BACKGROUND Chief Executive Officer, Revance Therapeutics, Inc., a commercial-stage biotechnology company (2019 to 2025) Chairman, President and Chief Executive Officer, ZELTIQ Aesthetics, Inc. (2012 to 2017); Executive Chairman (2009 to 2017) Managing Director, RWI Ventures, Inc. (2004 to 2018) Various Executive Positions for United States Surgical Corporation, Guidant Corporation, Devices for Vascular Intervention Inc., Perclose, Inc., and Ventrica, Inc. OTHER PUBLIC DIRECTORSHIPS Former Revance Therapeutics, Inc. (Nasdaq:RVNC) (2017 to 2025) SI-BONE, Inc. (Nasdaq:SIBN) (2019 to 2021) ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ) (2009-2017) EDUCATION Bachelor of Arts, University of Notre Dame KEY EXPERTISE PROVIDED TO THE BOARD : Mr. Foley has over 30 years of medical device operating, investment and chief executive officer experience. Mr. Foley s previous medical device experience as a senior executive and his service on the boards of several medical device public companies qualifies him to serve on our Board of Directors. KEY SKILLS : Capital Management Commercialization (U.S. and International) Executive Leadership Pharmaceutical Governance and Compliance Mergers and Acquisitions Medical Technology